[From aidsmap, January 17th 2019] “An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure to efavirenz was not statistically different, and may even be lower than in infants exposed to other antiretrovirals. The analysis by Professor Begoña Martinez de Tejada… Read More »Continue Reading →
[From Avert, January 16th 2019] “Young women in South Africa and Kenya would prefer injectable HIV prevention products that are multipurpose and can also prevent pregnancy over oral or ring-based pre-exposure prophylaxis (PrEP) products. The findings were revealed in a ‘discrete choice experiment’ (DCE) conducted among 536 women aged 18-30 in South Africa and Kenya… Read More »Continue Reading →
Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?
[From aidsmap, January 11th 2019] “A new meta-analysis of 20 studies and roll-out projects of HIV pre-exposure prophylaxis (PrEP) in gay and bisexual men confirms very high rates of diagnosis of sexually transmitted infections (STIs) in study participants and PrEP takers.” For more, click here.Continue Reading →
[From Saskatchewan Medical Association, January 10th 2019] “A Saskatchewan primary-care physician has a simple message for doctors who are thinking of expanding their capacity to care for people with HIV. “Do it!” said Dr. Laura Marshall, a La Ronge family physician. “It’s rewarding work, and clinically it is very interesting, but at the same time… Read More »Continue Reading →
[From aidsmap, January 4th 2019] “People with resistance to first- and second-line antiretroviral drugs can still achieve high rates of viral suppression in the first year on third-line regimens according to a South African study published in the January issue of the Journal of Acquired Immune Deficiency Syndromes.” For more, click here.Continue Reading →